Patient Profile:
-
47-year-old female
-
History of ischemic stroke at age 40 (no residual deficits)
-
Debilitating migraines since childhood (onset around age 5)
-
History of thyroid cancer
-
S/P total thyroidectomy
-
Currently stable on Synthroid
-
Also S/P appendectomy at age 2
-
No other major comorbidities reported
Clinical Question:
Before initiating peptide therapy, I’m looking for guidance on whether there are specific contraindications or cautions when prescribing peptides in patients with:
I would appreciate any experiences, literature references, or insights related to:
-
Safety considerations for common functional medicine peptides (e.g., BPC-157, TB-500, MOTS-C, AOD, etc.)
-
Any peptides known to exacerbate migraines
-
Any peptides with theoretical risks for increasing clotting, vasoconstriction, or neurologic issues
-
Recommended baseline labs or screening prior to initiation